Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 26,574 Shares
Analysts’ Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE), Apellis Pharmaceuticals (APLS) and ACADIA Pharmaceuticals (ACAD)
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), BioMarin Pharmaceutical (BMRN) and ACADIA Pharmaceuticals (ACAD)
Acadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development
Acadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Why Is Acadia (ACAD) Down 23.4% Since Last Earnings Report?
ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 17,714 Shares
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 Pharma Stocks to Sell in March Before They Crash & Burn
Biotech Stock Roundup: AMLX, ACAD Down on Study Data, MRNA, RGLS Gain on Updates & More
Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day
Acadia Hits 11-Month Low After Outsized Placebo Effect Torpedoes Schizophrenia Study
Stocks making the biggest moves midday: Southwest, Oracle, 3M, New York Community Bancorp and more
Acadia (ACAD) Down as Schizophrenia Study on Nuplazid Fails
Analysts Are Bullish on Top Healthcare Stocks: ACELYRIN, INC. (SLRN), ZyVersa Therapeutics (ZVSA)
ACADIA Pharmaceuticals Maintains Buy Rating Despite Price Target Adjustment
Acadia (NASDAQ:ACAD) Plunges as Pimavanserin Disappoints in Phase 3 Trial
Maintaining Hold on ACADIA Pharmaceuticals Amid Clinical Setbacks and Valuation Adjustments
Analysts Have Conflicting Sentiments on These Healthcare Companies: Legend Biotech (LEGN), ACADIA Pharmaceuticals (ACAD) and CytomX Therapeutics (CTMX)
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.